Archive Newsletter

  1. 08.05.24 -- New FDA QMSR: Its Role In Part 4 Compliance For Combination Products 8/5/2024
    08/05/24 Drug Delivery Leader Newsletter
  2. 07.29.24 -- Trans-Arterial Micro-Perfusion For Improved Drug Delivery 7/29/2024
    07/29/24 Drug Delivery Leader Newsletter
  3. 07.22.24 -- A Critical Analysis Of FDA Human Factors IFU Guidance For Drug Delivery Devices 7/22/2024
    07/22/24 Drug Delivery Leader Newsletter
  4. 07.15.24 -- How The Right Operating Model For EU MDR Compliance Can Support A Global Footprint 7/15/2024
    07/15/24 Drug Delivery Leader Newsletter
  5. 07.11.24 -- Frankly Fran: Embrace Packaging And Delivery Systems Designed For Today's Standards 7/11/2024
    07/11/24 Drug Delivery Leader Newsletter
  6. 07.08.24 -- Integrating Risk Management With The Design Control Process 7/8/2024
    07/08/24 Drug Delivery Leader Newsletter
  7. 07.01.24 -- Balancing Sustainability With Patient Safety In Medical Device Design 7/1/2024
    07/01/24 Drug Delivery Leader Newsletter
  8. Best of June: Top 5 Insights In Drug Formulation and Delivery 6/27/2024
  9. 06.27.24 -- An Innovative Approach To Mitigate Nitrosamine Risks 6/27/2024

    06/27/24 Drug Delivery Leader Newsletter

  10. 06.25.24 -- Ensure Success And Speed-To-Market With Drug Delivery Projects 6/25/2024

    06/25/24 Drug Delivery Leader Newsletter